Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Common Equity (2016 - 2025)

Qiagen (QGEN) has disclosed Common Equity for 17 consecutive years, with $3.8 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 5.91% to $3.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 billion through Dec 2025, up 5.91% year-over-year, with the annual reading at $3.8 billion for FY2025, 5.91% up from the prior year.
  • Common Equity hit $3.8 billion in Q4 2025 for Qiagen, up from $3.6 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $3.8 billion in Q4 2023 to a low of $3.1 billion in Q4 2021.
  • Historically, Common Equity has averaged $3.5 billion across 5 years, with a median of $3.6 billion in 2024.
  • Biggest five-year swings in Common Equity: increased 11.95% in 2022 and later decreased 6.31% in 2024.
  • Year by year, Common Equity stood at $3.1 billion in 2021, then grew by 11.95% to $3.5 billion in 2022, then increased by 9.84% to $3.8 billion in 2023, then dropped by 6.31% to $3.6 billion in 2024, then increased by 5.91% to $3.8 billion in 2025.
  • Business Quant data shows Common Equity for QGEN at $3.8 billion in Q4 2025, $3.6 billion in Q4 2024, and $3.8 billion in Q4 2023.